14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
CNVS vs MCS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, The Marcus Corporation (MCS) is the stronger overall head-to-head candidate over Cineverse Corp. (CNVS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CNVS carries a Unified Composite Score of 35.9/100 (SELL) at $1.73 (38.8x Forward P/E, -12.0% operating margin), whereas MCS carries 46.5/100 (HOLD) at $25.67 (29.9x Forward P/E, 5.7% operating margin).
Growth vs. Quality Trade-Off: MCS earns the overall head-to-head edge with a stronger Unified Composite Score (46.5/100 HOLD vs. CNVS 35.9/100 SELL) and 0.67β · 30% Vol risk profile, whereas CNVS leads top-line expansion (+110.0% YoY revenue growth, 0.46x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CNVS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.9); meanwhile MCS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CNVS vs MCS. Trailing 12-month operating profitability (CNVS -12.0% vs MCS 5.7%) and valuation multiples (CNVS 38.8x vs MCS 29.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Entertainment value chain with $807.1M market capitalization and 5.7% operating margin.
OpEx & R&D Reinvestment36.0% of Rev ($279M)
90D Engineering Disclosures0 Published
Investor FAQ CNVS vs MCS Key Questions & Quantitative Answers
As of Nov 20, 2026, The Marcus Corporation (MCS) is the stronger overall head-to-head candidate over Cineverse Corp. (CNVS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CNVS carries a Unified Composite Score of 35.9/100 (SELL) at $1.73 (38.8x Forward P/E, -12.0% operating margin), whereas MCS carries 46.5/100 (HOLD) at $25.67 (29.9x Forward P/E, 5.7% operating margin). Growth vs. Quality Trade-Off: MCS earns the overall head-to-head edge with a stronger Unified Composite Score (46.5/100 HOLD vs. CNVS 35.9/100 SELL) and 0.67β · 30% Vol risk profile, whereas CNVS leads top-line expansion (+110.0% YoY revenue growth, 0.46x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CNVS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.9); meanwhile MCS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CNVS leads the Growth & Scale pillar: CNVS posts +110.0% YoY revenue growth and +21.1% YoY earnings growth on $99M TTM revenue (42.7% gross margin, -12.0% operating margin), compared with MCS at +13.3% YoY revenue growth and +14.4% YoY earnings growth on $774M TTM revenue (41.7% gross margin, 5.7% operating margin). On trailing 12-month operating scale, CNVS generates $99M in USD-normalized revenue versus $774M for MCS. In operating R&D and SG&A reinvestment, CNVS deploys 54.7% of Rev ($54M) (0 90-day corporate R&D disclosures) versus 36.0% of Rev ($279M) (0 disclosures) for MCS.
MCS screens cheaper on headline valuation multiples. CNVS trades at 38.8x Forward P/E, 38.8x Trailing P/E, 0.46x PEG, and 0.7x EV/Revenue (-17.9% FCF margin), whereas MCS trades at 29.9x Forward P/E, 30.9x Trailing P/E, 4.11x PEG, and 1.0x EV/Revenue (14.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CNVS (-4.6% ROE) versus MCS (5.4% ROE) capital efficiency.
In options market volatility and institutional positioning, CNVS carries 131.8% implied volatility (28th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 110% Vol realized risk). By comparison, MCS carries 100.5% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.67β · 30% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.